Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.
Semaglutide medications — such as Ozempic, the popular diabetes drug — have been linked to a reduced risk of Alzheimer’s disease for certain groups. A new study, which was led by researchers at Case Western Reserve University in Cleveland, Ohio, revealed that patients who were prescribed semaglutide had a 'significantly lower risk' of developing Alzheimer’s compared to those taking other types of anti-diabetic medications, according to a press release.
The researcher also acknowledged that the study had some limitations. 'This is a retrospective cohort study with inherent limitations related to uncontrolled or unmeasured confounding and biases,' she said. 'Further research into semaglutide’s use will need to be further investigated through randomized clinical trials so alternative drugs can be tested as potential treatment for this debilitating illness.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy vs. Ozempic: How the 2 Drugs Are DifferentWegovy and Ozempic use the same semaglutide medication but at different doses. Here's what to know about Wegovy vs. Ozempic.
Read more »
Semaglutide may reduce opioid overdoses, a new study suggests A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.
Read more »
Semaglutide a Potential Treatment Option for Opioid Use Disorder?Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 diabetes and opioid use disorder.
Read more »
Semaglutide saps mice’s motivation to runMice given semaglutide, the key ingredient in drugs like Ozempic and Wegovy, lost weight, but they also voluntarily ran less on a wheel.
Read more »
Hidradenitis Suppurativa Symptoms Eased by Semaglutide-Aided Weight LossImprovements in the Dermatology Life Quality Index score and hidradenitis suppurativa flares were seen in people who achieved semaglutide-induced weight loss.
Read more »
Topline: Oral Semaglutide Cuts Cardiovascular Events in T2DIn Novo Nordisk’s randomized clinical trial, semaglutide reduced the risk for major adverse cardiovascular events by 14% compared with placebo.
Read more »